Cargando…
4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium 2-hydroxybenzoate 2-hydroxybenzoic acid monosolvate
The title compound, C(17)H(19)F(2)N(2) (+)·C(7)H(5)O(3) (−)·C(7)H(6)O(3), is a co-crystal from 4-[bis(4-fluorophenyl)methyl]piperazin-1-ium, salicylate anion and salicylic acid in a 1:1:1 ratio. In addition to an intramolecular O—H⋯O hydrogen bond, the crystal packing shows hydrogen bonds betwe...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344118/ https://www.ncbi.nlm.nih.gov/pubmed/22606121 http://dx.doi.org/10.1107/S1600536812012329 |
Sumario: | The title compound, C(17)H(19)F(2)N(2) (+)·C(7)H(5)O(3) (−)·C(7)H(6)O(3), is a co-crystal from 4-[bis(4-fluorophenyl)methyl]piperazin-1-ium, salicylate anion and salicylic acid in a 1:1:1 ratio. In addition to an intramolecular O—H⋯O hydrogen bond, the crystal packing shows hydrogen bonds between the piperazinium cation and salicylate anion (N—H⋯O), as well as between the salicylic acid molecule and anion (O—H⋯O), giving rise to a three-dimensional network. |
---|